PATENT CLAIM ANALYSIS

Application Number: 16253077
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["424", "133100"]

Abstract:
The present invention relates to monoclonal antibodies that bind or neutralize anthrax protective antigen (PA) toxin. The invention provides such antibodies, fragments of such antibodies retaining anthrax PA toxin-binding ability, fully human or humanized antibodies retaining anthrax PA toxin-binding ability, and pharmaceutical compositions including such antibodies. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. Additionally, the invention provides for prophylactic, therapeutic, and diagnostic methods employing the antibodies and nucleic acids of the invention.

Claim (Index 26):
The method of  claim 19 , wherein said monoclonal antibody comprises a heavy chain Fd region including the amino acid sequence of SEQ ID NO: 1 (when heavy chain CDR3 region is SEQ ID NO: 7) or SEQ ID NO: 17 (when heavy chain CDR3 region is SEQ ID NO: 23).

Metadata:
- Claim Count in Document: 11.0
- Percentile: 99.0
- Lexical Diversity: 1.88235
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11793735', '14031508', '12528427', '13310463', '14181099']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8092404935868862
- 35 USC 102 Novelty (BERT): 0.5735107168638468
- Combined Prediction Score: 0.7856675159145823
- Mean Citation Score: 449.78025400000007
- Max Citation Score: 516.8979
- Similarity Product: 366.97269624842414

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test